Please login to the form below

Not currently logged in
Email:
Password:

Mvasi

This page shows the latest Mvasi news and features for those working in and with pharma, biotech and healthcare.

First Humira biosimilars reach EU market

First Humira biosimilars reach EU market

For Amgen it is its second biosimilar product approval in Europe after Mvasi (bevacizumab), a version of Roche’s cancer drug Avastin.

Latest news

More from news
Approximately 3 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...

Infographics